Sanofi-Aventis Pipeline Includes Sleep Quality Aid, Depression Therapy

Positive early clinical results for Sanofi-Aventis' sleep disorder therapy eplivanserin could lead to the development of a "new concept" for improving quality of sleep, Senior Exec VP-Science & Medical Affairs Gerard Le Fur said